Pharmacology of a 40 IU/ml porcine lente insulin preparation in diabetic cats: Findings during the first week and after 5 or 9 weeks of therapy

Journal of Feline Medicine and Surgery

Volumn 3, Issue 1, 2001, Pages 23-30

  Martin, G J ^a   Rand, J S ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; LONG ACTING INSULIN;

ANIMAL; ANIMAL DISEASE; AREA UNDER THE CURVE; ARTICLE; BLOOD; CAT; CAT DISEASE; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; POSTPRANDIAL STATE; SUBCUTANEOUS DRUG ADMINISTRATION; SWINE;

ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; CAT DISEASES; CATS; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN, LONG-ACTING; MALE; POSTPRANDIAL PERIOD; SWINE;

FELIDAE; FELIS CATUS; SUIDAE;

EID: 0035285699     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1053/jfms.2001.0111     Document Type: Article

References (34)

1. Bertoy E.H., Nelson R.W., Feldman E.C. Effect of lente insulin for treatment of diabetes mellitus in 12 cats. Journal of the American Veterinary Medical Association. 206:1995;1729-1731.
2. Binder C., Lauritzen T., Faber O., Pramming S. Insulin pharmacokinetics. Diabetes Care. 7:1984;188-199.
3. Brange J., Owens D.R., Kang S., Volund A. Monomeric insulins and their experimental and clinical implications. Diabetes Care. 13:1990;923-954.
4. Broussard J.D., Peterson M.E. Comparison of two ultralente insulin preparations with protamine zinc insulin in clinically normal cats. American Journal of Veterinary Research. 55:1994;127-131.
5. Brown S.A., Nelson R.W., Bottoms G.D. Models for the pharmacokinetics and pharmacodynamics of insulin in alloxan-induced diabetic dogs. Journal of Pharmaceutical Sciences. 76:1987;295-299.
6. de Meijer PHEM, Russel F.G.M., Van Lier H.J.J., Van Ginneken C.A.M. A comparison of three mathematical models to describe the disappearance curves of subcutaneously injected 125-I labelled insulin. British Journal of Clinical Pharmacology. 27:1989;461-467.
7. Ferrannini E., Cobelli C. The kinetics of insulin in man. I. General aspects. Diabetes/Metabolism Reviews. 3:1987;335-363.
8. Frier B.M., Sullivan F.M., Mair F.S., Koch I.M., Scotton J.B. Pharmokinetics of human insulin zinc suspension (recombinant DNA) in normal man: a comparison with porcine insulin zinc suspension. Diabetic Medicine. 1:1984;219-221.
9. Gardner D.F., Wilson H.K., Podet E.J., Arakaki R.F., Nell L.J., Thomas J.W., Crane M.M., Field J.B. Prolonged action of regular insulin in diabetic patients: lack of relationship to circulating insulin antibodies. Journal of Clinical Endocrinology and Metabolism. 62:1986;621-627.
10. Garvey W.T., Olefsky J.M., Griffin J., Hamman R.F., Kolterman O.G. The effect of insulin treatment on insulin secretion and action in type 2 diabetes mellitus. Diabetes. 34:1985;222-234.
11. Graham P.A., Nash A.S., McKellar Q.A. Pharmacokinetics of a porcine insulin zinc suspension in diabetic dogs. Journal of Small Animal Practice. 38:1997;434-438.
12. Greco D.S., Broussard J.D., Peterson M.E. Insulin therapy. Veterinary Clinics of North America. Small Animal Practice. 25:1995;677-690.
13. Hallas-Møller K., Jersild M., Peterson K., Schlichtkrull J. The lente insulins. Insulin zinc suspensions. Danish Medical Bulletin. 1:1954;132-142.
14. Heding L.G. Determination of total serum insulin (IRI) in insulin treated diabetic patients. Diabetologia. 8:1972;260-266.
15. Hildebrandt P. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Danish Medical Bulletin. 38:1991;337-346.
16. Ihle S.L., Nelson R.W. Insulin resistance and diabetes mellitus. Compendium on Continuing Education for the Practicing Veterinarian. 13:1991;197-203.
17. Kurtz A.B., Nabarro J.D.N. Circulating insulin-binding antibodies. Diabetologia. 19:1980;329-334.
18. Link, KRJ, 2000, Feline Diabetes: Diagnostics and Experimental Modelling (PhD thesis).
19. Link K.R.J., Rand J.S. Journal of Veterinary Internal Medicine. 10:1996) Glucose toxicity in cats (Abstract);185.
20. Martin, GJ, Rand, JS, 1999, The Efficacy of 40 IU/ml Porcine Lente Insulin for the Treatment of Feline Diabetes Mellitus (Abstract), WSAVA, Lyon, France.
21. Martin G.J.W., Rand J.S. Evaluation of a polyurethane jugular catheter in cats placed using a modified Seldinger technique. Australian Veterinary Journal. 77:1999;250-254.
22. McMillan F.D., Feldman E.C. Rebound hypoglycemia following overdosing of insulin in cats with diabetes mellitus. Journal of the American Veterinary Medical Association. 188:1986;1426-1431.
23. Moise N.S., Riemers T.J. Insulin therapy in cats with diabetes mellitus. Journal of the American Veterinary Medical Association. 182:1983;158-164.
24. Mosekilde E., Jensen K.S., Binder C., Pramming S., Thorsteinsson B. Modeling absorption kinetics of subcutaneous injected soluble insulin. Journal of Pharmacokinetics and Biopharmaceutics. 17:1989;67-87.
25. Nagakawa S., Nakayama H., Sasaki T., Yoshino K., Ying Yu Y., Shinozaki K., Aoki S., Mashino K. A simple method for the determination of free insulin levels in insulin treated diabetic patients. Diabetes. 22:1973;590-600.
26. Nelson R.W. Insulin resistance in dogs and cats. Bonagura J. Kirk's Current Veterinary Therapy. 1995;390-393.
27. Nelson R.W., Brown S.A., Jones R.J., Smith P., Bottoms G.D. Absorption kinetics of regular insulin in dogs with alloxan-induce diabetes mellitus. American Journal of Veterinary Research. 51:1990;1671-1674.
28. Nelson R.W., Feldman E.C., DeVries S.E. Use of ultralente insulin in cats with diabetes mellitus. Journal of the American Veterinary Medical Association. 200:1992;1828-1829.
29. Panciera D.L., Thomas C.B., Eicker S.W., Atkins C.E. Epizootiological patterns of diabetes mellitus in cats: 333 cases (1980-1986). Journal of the American Veterinary Medical Association. 197:1990;1504-1508.
30. Rand J.S., Bobbermien L.M., Hendrikz J.K., Copland M. Over representation of Burmese cats with diabetes mellitus. Australian Veterinary Journal. 75:1997;402-405.
31. Rowland M., Tozer T.N. Appendix A: Assessment of Area. Clinical pharmacokinetics: Concepts and Applications. 1989;Lea and Febiger, Philadelphia. p. 459-471.
32. Rowland M., Tozer T.N. Turnover concepts. Clinical Pharmacokinetics: concepts and applications. 1995;Lea and Febiger, Baltimore. p. 424-441.
33. Rudkowski R., Antony G. The effect of immediate polyethylene glycol precipitation on free insulin measurements in diabetic patients with insulin antibodies. Diabetes. 35:1986;253-257.
34. Wallace M.S., Peterson M.E., Nichols C.E. Absorption kinetics of regular, isophane and protamine zinc insulin in normal cats. Domestic Animal Endocrinology. 7:1990;509-515.